CannaRoyalty Corp., doing business as Origin House, is a Canada-based company. The Company is growing cannabis brands and distribution company in United States and Canada. The Company acts as a brand development platform by distribution, manufacturing, cultivation, and marketing services for it's clients. The Company is also developing infrastructure to support their customers.

Employees

Sector

Pharmaceuticals

More about the company

Delayed Canadian Securities Exchange			5-day change	1st Jan Change
- ^CAD	-.--%		-7.47%	-10.42%

30/03/21	Spyder Cannabis Inc. completed the acquisition of 180 Smoke LLC from Origin House for CAD 1.	CI
23/02/21	Spyder Cannabis Inc. entered into a binding agreement to acquire 180 Smoke LLC from Origin House.	CI

Market Cap	513M 443M 416M 379M 713M 48.71B 717M 4.92B 1.92B 24.78B 1.93B 1.89B 82.15B	P/E 2017	-17.4x	P/E 2018	-41.8x
Enterprise Value	460M 397M 373M 340M 640M 43.67B 643M 4.41B 1.72B 22.21B 1.73B 1.69B 73.66B	EV / Sales 2017	53,919,197x	EV / Sales 2018	19,487,976x
Free-Float	80.58%	Yield 2017 *	-	Yield 2018	-

30/03/21	Spyder Cannabis Inc. completed the acquisition of 180 Smoke LLC from Origin House for CAD 1.	CI
23/02/21	Spyder Cannabis Inc. entered into a binding agreement to acquire 180 Smoke LLC from Origin House.	CI
28/01/21	Driven Deliveries, Inc. cancelled the acquisition of Humboldt's Finest Farms.	CI
28/01/20	Driven Deliveries, Inc. signed a letter of intent to acquire Humboldt's Finest Farms.	CI
08/01/20	Cresco Labs Inc. (CNSX:CL) completed the acquisition of Origin House (CNSX:OH).	CI
31/12/19	Origin House Strengthens Partnership with Kings Garden Inc	CI
29/11/19	Tranche Update on Origin House's Equity Buyback Plan announced on August 9, 2018.	CI
26/11/19	Origin House announced that it has received CAD 39.599999 million in funding	CI
13/11/19	Origin House announced that it expects to receive CAD 39.599999 million in funding	CI
15/10/19	Origin House Announces Full Integration with California Cannabis Track-and-Trace System	CI
15/10/19	An unknown acquired Distribution and Manufacturing Facility in Sonoma County from Origin House (CNSX:OH) for $1.7 million.	CI
04/10/19	Cannaroyalty Corp. Signs Distribution Agreement with California Cannabis Infused Beverage Brand Cannabiniers	CI
03/10/19	Origin House Announces Executive Changes	CI

09/01/20	Origin House : Cresco Closes Acquisition of Origin House, Adding Leading California Wholesale Distribution and Cultivation Operations to Its Strategic National Footprint	BU
08/01/20	Origin House : Bhang and Origin House Mutually Terminate License Agreement	AQ
07/01/20	Origin House : Obtains Final Order for Proposed Arrangement with Cresco Labs Inc.	AQ
03/01/20	Origin House : Receives Shareholder Approval of Plan of Arrangement with Cresco Labs and Announces Extension and Addition of OCN Debt Facility	AQ
01/01/20	Origin House : Receives Shareholder Approval of Plan of Arrangement with Cresco Labs Inc. and Announces Extension and Addition of OCN Debt Facility	AQ

Origin House Stock

Stocks

OH

CA1376441004

Pharmaceuticals

Valuation : Origin House

Latest news : Origin House

Press Releases : Origin House

News in other languages : Origin House

Latest insider transactions

Alternative Medicine

Financials

Company Profile

Date	Insider	Type	Quantity	% Market Cap.	Importance
10/1/20	Marc Lustig	Other	1	0.0000%	-
10/1/20	Marc Lustig	Marche	171,335	0.2191%
10/1/20	Marc Lustig	Marche	1,879,825	2.4039%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORIGIN HOUSE	-.--%	-7.47%	-	-	352M
YUNNAN BAIYAO GROUP CO.,LTD	-0.16%	+1.20%	-14.66%	-7.26%	13.45B
BEIJING TONGRENTANG CO., LTD	-0.71%	-1.69%	-33.92%	-56.88%	4.9B
DONG-E-E-JIAO CO., LTD.	-0.36%	-3.01%	-8.51%	-5.52%	4.52B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-1.81%	-2.11%	-5.86%	-31.64%	3.99B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.72%	-0.61%	-21.46%	+1.39%	3.57B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-2.27%	+0.32%	-2.80%	-4.50%	3.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.88%	-0.81%	-11.39%	+4.57%	3.28B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-1.46%	-3.14%	-25.48%	-14.97%	2.36B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-1.08%	+0.15%	-27.68%	-16.31%	1.72B
Average	-0.94%	-2.34%	-16.86%	-14.57%	4.16B
Weighted average by Cap.	-0.80%	-1.14%	-15.90%	-14.21%

	2017	2018
Net sales	3.08 2.66 2.5 2.28 4.28 292.12 4.3 29.53 11.49 148.59 11.56 11.31 492.71	18.69 16.12 15.17 13.82 25.98 1.77K 26.13 179.31 69.79 902.44 70.18 68.66 2.99K
Net income	-8.89M -7.67M -7.21M -6.57M -12.36M -844M -12.43M -85.29M -33.2M -429M -33.38M -32.66M -1.42B	-8.41M -7.26M -6.83M -6.22M -11.7M -799M -11.76M -80.71M -31.41M -406M -31.59M -30.91M -1.35B
Net Debt	-1.84M -1.59M -1.49M -1.36M -2.56M -175M -2.57M -17.64M -6.87M -88.77M -6.9M -6.75M -294M	-53.08M -45.78M -43.07M -39.23M -73.78M -5.04B -74.18M -509M -198M -2.56B -199M -195M -8.5B